TrademarkDir
FIDELIS
DEAD

Serial Number

97455050

Owner

FIDELIS ANIMAL HEALTH, INC.

Attorney

Frederic M. Wilf

First Use Date

Aug 6, 2020

Filing Date

Jun 13, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FIDELIS Trademark

Serial Number: 97455050

FIDELIS is a trademark filed by FIDELIS ANIMAL HEALTH, INC. on June 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

FIDELIS ANIMAL HEALTH, INC. (4 trademarks)

675 HIGHWAY ONE
NORTH BRUNSWICK, NJ 08902

Entity Type: 03

Trademark Details

Filing Date

June 13, 2022

Registration Date

Not Registered

First Use Anywhere

August 6, 2020

First Use in Commerce

August 6, 2020

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 12, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 12, 2024 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 18, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 18, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 18, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 11, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 18, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 3, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 3, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 3, 2023 CNSL
ASSIGNED TO EXAMINER
Mar 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2022 NWOS
NEW APPLICATION ENTERED
Jun 16, 2022 NWAP

Related Trademarks

More from this Owner

ETHIQA XR

ETHIQA XR

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML logo

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

FIDELIS PHARMACEUTICALS

FIDELIS PHARMACEUTICALS